Medtronic Inc.’s (NYSE:MDT) chief regulatory affairs officer Susan Alpert will join her boss, William Hawkins, on Retirement Row this year, according to company officials.
Alpert, who has held the senior vice president and chief regulatory officer positions at Medtronic since 2005, had a similar role at C.R. Bard (NYSE:BCR) before joining MDT and is also a former director of the FDA’s Office of Device Evaluation .
Spokesman Brian Henry confirmed Alpert’s retirement to MassDevice in an email, writing that she will step down as of the end of Medtronic’s fiscal year later this month.
"It’s been an absolute pleasure working with her. Her knowledge of the industry, of regulatory agencies and of the importance of collaboration between the two for the benefit of patients, is unsurpassed," Henry told us. "Her guidance and counsel have been extremely valuable and we’re pleased that she plans to continue to offer both even in her retirement."
Henry said the Fridley, Minn.-based company has already tapped Alpert’s replacement, regulatory affairs vice president Patricia Shrader. Shrader, the former regulatory SVP at Becton, Dickinson & Co. (NYSE:BEC).
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- HEP forms life science team
Health Evolution Partners (HEP), a manager of health care investment funds, formed of a life sciences team in the Health Evolution Partners Growth Fund. The team will focus on investments in commercial-stage life sciences companies with the potential to be market leaders in many sectors, including medical devices/products, specialty pharmaceuticals, drug delivery technologies, outsourcing, manufacturing and research.
- Paul Maeder wins chairmanship at NVCA
The National Venture Capital Association (NVCA) today elected Paul Maeder, Co-Founder and General Partner of Highland Capital Partners, to serve as the 2011-2012 Chairman of the Board of Directors. The appointment was made official before the hundreds of venture capitalists attending this year’s NVCA Annual Meeting in Boston. Mr. Maeder’s one-year term began April 7.
- OraSure Technologies appoints Stephen Tang to board
OraSure Technologies Inc. (NSDQ:OSUR) appointed Stephen Tang as a member of the Company’s Board of Directors. Dr. Tang will serve as a Class I Director with an initial term expiring at the Company’s 2013 Annual Meeting of Stockholders.
- GenMark taps Hany Massarany for top spot
GenMark Diagnostics Inc. (NSDQ:GNMK), a provider of automated molecular diagnostic testing systems, today announced that the Board of Directors has appointed Hany Massarany as President and Chief Executive Officer and a member of the Board of Directors.
- HemaCare names Dr. Scott Burger SAB chair
HemaCare Corp. (OTC:HEMA) today named Dr. Scott Burger as the Chairperson of its Scientific Advisory Board. HemaCare has also engaged Dr. Burger, a world renowned cell therapy expert, in a comprehensive consulting services agreement. Dr. Burger will be a key agent in the aggressive expansion of HemaCare’s role in the rapidly developing fields of stem cells and cellular therapies, regenerative medicine, and immunotherapy.
- Stephen Bumb joins Toshiba as director of X-ray vascular unit
Toshiba America Medical Systems Inc. announced that Stephen Bumb has been named director, X-ray Vascular Business Unit. As the new director, Bumb is responsible for implementing strategic and tactical marketing plans to drive growth. He will also interface with the global business unit at Toshiba Medical Systems Corp. to communicate the needs and requirements of the U.S. market.
- Cadence expands executive team
Cadence Inc. announced that Alan Connor has joined the company as President. Alan joins the company following years in key leadership roles for major healthcare and life science companies, including most recently as the Vice President and General Manager of Orthopedic Specialties for MicroAire Surgical Instruments in Charlottesville, Va.
- Cappella names Shea CEO
Capella Medical Devices announced the appointment of Paul Shea as its CEO. Paul will be based at Cappella’s headquarters in Galway, Ireland. Paul comes to Cappella with thirty years experience in the medical device industry. Paul recently served as Senior Vice President of Sales at Sentinelle Medical and previously was Vice President of Sales at Traxral, Inc., and Angiodynamics and also held various sales and marketing positions at Boston Scientific Corporation. In addition, Dr. Art Rosenthal who recently served as Cappella’s CEO has been promoted to Executive Vice Chairman and will be responsible for strategic partnering, clinical development and networking initiatives.
- Flexible Stenting taps former Micrus COO for board
Flexible Stenting Solutions Inc., a developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today the addition of Robert Stern, former President and COO of Micrus Endovascular, has been elected to its board of directors.
- CareFusion COO out
CareFusion (NYSE:CFN) announced the COO Dwight Winstead will leave the company on June 30. Winstead has served as COO since CareFusion separated from Cardinal Health on September 2009, during which time he had responsibility for sales, marketing, R&D and manufacturing for the company’s business segments. He joined Cardinal Health in 1997 and held a variety of positions including president of the Clinical Technologies and Services business and group president for Cardinal Health’s Automation and Information Services segment.